✦ LIBER ✦

Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)

✍ Scribed by Rosenstock, Julio; Hanefeld, Markolf; Shamanna, Paramesh; Min, Kyung Wan; Boka, Gabor; Miossec, Patrick; Zhou, Tianyue; Muehlen-Bartmer, Isabel; Ratner, Robert E.

Book ID: 122273721
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 386 KB
Volume: 28
Category: Article
ISSN: 1056-8727
DOI: 10.1016/j.jdiacomp.2014.01.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)

✍ Y. Seino; K. W. Min; E. Niemoeller; A. Takami; on behalf of the EFC10887 GETGOAL 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB